Search results for " Lymphadenectomy"

showing 10 items of 23 documents

Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer …

2022

Background and Objectives: We aimed to evaluate Progression Free Survival (PFS), Overall Survival (OS), and relapse rate in women affected by endometrioid ovarian cancer and synchronous endometrial-ovarian endometrioid cancer (SEO-EC). As secondary outcome, we assessed whether systematic pelvic and para-aortic lymphadenectomy could be considered a determinant of relapse rate in this population. Materials and Methods: We performed a retrospective analysis of women with diagnosis of endometrioid ovarian cancer or SEO-EC between January 2010 to September 2020, and calculated PFS, OS and relapse rate. Results: In almost all the patients (97.6%) who underwent systematic pelvic and para-aortic ly…

Gynecological oncologyGynecological cancerendometrioid ovarian cancer; synchronous endometrial-ovarian endometrioid cancer; lymphadenectomy; gynecological surgery; gynecological oncology; gynecological cancerEndometrioid ovarian cancerGynecological surgeryLymphadenectomyGeneral MedicineSynchronous endometrial-ovarian endometrioid cancerSettore MED/40 - Ginecologia E OstetriciaMedicina; Volume 58; Issue 12; Pages: 1706
researchProduct

Stadification ganglionnaire lombo-aortique dans les cancers du col de stade supérieur ou égal à IB2: comparaison des performances du PETscan au 18FDG…

2021

Resume Introduction Les recommandations actuelles (ASCO, ESTRO, ESGO) preconisent la realisation d’un curage lombo-aortique (CLAO) de stadification ganglionnaire en cas de negativite au PETscan d’evaluation initiale dans les cancers du col localement avance (CCLA), afin d’adapter les champs d’irradiation de la radiochimiotherapie. L’objectif principal etait de comparer la survie globale (SG) entre deux groupes (iN- au PETscan versus iN- et pN- au PETscan et CLAO) qui different par leur technique de stadification ganglionnaire lombo-aortique: stadification par imagerie seule versus imagerie et chirurgie. Les objectifs secondaires etaient de determiner la survie sans recidive (SSR), le taux d…

Gynecology03 medical and health sciencesmedicine.medical_specialty030219 obstetrics & reproductive medicine0302 clinical medicineReproductive Medicinebusiness.industry030220 oncology & carcinogenesismedicineObstetrics and GynecologyPara aortic lymphadenectomybusinessGynécologie Obstétrique Fertilité & Sénologie 
researchProduct

Successful in vitro fertilization and embryo transfer after limited surgical treatment for tubal adenocarcinoma.

1989

A 29-year-old woman with tubal adenocarcinoma stage IA was treated only with bilateral salpingectomy, pelvic lymphadenectomy, and omentectomy. Two years later the patient successfully underwent in vitro fertilization and embryo transfer, and at 39 weeks gave birth to a healthy son by cesarean section. The result of oncologic follow-up 3 years after surgery is negative.

MaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentFertilization in VitroAdenocarcinomaBilateral SalpingectomyPostoperative ComplicationsPregnancymedicineFallopian Tube NeoplasmsHumansStage (cooking)Pelvic lymphadenectomySurgical treatmentGynecologyIn vitro fertilisationbusiness.industryInfant NewbornFallopian Tube Diseasesmedicine.diseaseEmbryo TransferEmbryo transferTuberculosis Female GenitalOmentectomyOncologyAdenocarcinomaFemalebusinessInfertility FemaleCancer
researchProduct

Risk factors, complications and management of lymphocele formation after radical prostatectomy: A mini‐review

2019

Lymphocele formation is the most common adverse event of pelvic lymphadenectomy during radical prostatectomy for prostate cancer. Previous studies failed to favor one surgical technique over the other in terms of minimizing its rate. Data on risk factors for its development are still conflicting and warranting further research. In this mini-review, we aimed to scrutinize available evidence on these aspects and outline current achievements in lymphocele prevention approaches.

Malemedicine.medical_specialtyLymphoceleUrologymedicine.medical_treatment030232 urology & nephrologyPelvisMini review03 medical and health sciencesLymphoceleProstate cancer0302 clinical medicineRisk FactorsHumansMedicineAdverse effectPelvic lymphadenectomyProstatectomybusiness.industryProstatectomyGeneral surgeryProstatic Neoplasmsmedicine.disease030220 oncology & carcinogenesisLymph Node ExcisionbusinessInternational Journal of Urology
researchProduct

A Proposal for Novel Standards of Histopathology Reporting for D3 Lymphadenectomy in Right Colon Cancer: The Mesocolic Sail and Superior Right Colic …

2020

Background Strong agreement exists concerning the standards of pathologic reporting for total mesorectal excision and complete mesocolic excision. It represents a quality standard that correlates with survival. However, no agreed standards of reporting are available to define D3 lymphadenectomy for right colectomy. Objective The purpose of this study was to define anatomopathological standards of specimen quality obtained from the surgical specimen when an oncologic right hemicolectomy with D3 lymphadenectomy has been correctly performed. Design This study was conducted in 2 different phases. The first part consisted of a cadaver-based study of right colon anatomy, and the second part consi…

Malemedicine.medical_specialtySurgical specimen03 medical and health sciencesMesenteric Veins0302 clinical medicineD3 lymphadenectomyCadaverHumansMedicineD3 lymphadenectomyProspective StudiesColectomyAgedNeoplasm StagingAged 80 and overNew quality standardsbusiness.industryRight colic veinGastroenterologyOutcome measuresGeneral MedicineMiddle AgedColon cancermedicine.anatomical_structureSpecimen QualityLymphatic Metastasis030220 oncology & carcinogenesisQuality standardColonic NeoplasmsRight ColectomyLymph Node ExcisionFemaleLaparoscopy030211 gastroenterology & hepatologyHistopathologyLymph NodesAnatomic LandmarksbusinessNuclear medicineFollow-Up StudiesDiseases of the Colon & Rectum
researchProduct

Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial.

1980

Summary— Forty-two patients with previously untreated T3/4 N1-4 MO/1 prostatic adenocarcinoma were treated with either cyproterone acetate (n=21; 300 mg intramuscularly per week) or oestradiol undecylate (n=21; 100 mg intramuscularly per month) after extensive staging which included open skeletal biopsy and pelvic lymphadenectomy in some cases. Subjective and objective parameters as well as signs of drug toxicity were recorded regularly. Evaluation after 6 months showed cyproterone acetate to be more effective in the following respects: (1) the significantly different castration effect as judged by plasma testosterone, (2) the objective voiding pattern and tumour response, with regression o…

Malemedicine.medical_specialtyTime FactorsUrologyUrologyAdenocarcinomachemistry.chemical_compoundRandom AllocationBiopsymedicineHumansCyproteronePelvic lymphadenectomyDrug toxicityTestosteroneAgedClinical Trials as Topicmedicine.diagnostic_testEstradiolProstatic adenocarcinomabusiness.industryCyproterone acetateCancerProstatic NeoplasmsMiddle Agedmedicine.diseaseSurgeryCastrationchemistrybusinessBritish journal of urology
researchProduct

Open Radical Nephrectomy: 35 Years of Experience at the “Luciano Giuliani” Urological Department of the University of Genoa

2006

Objective: Radical nephrectomy remains the gold standard for surgically resectable kidney neoplasms > 4 cm and, in selected cases, also in presence of metastatic disease. We reviewed the records of the patients having surgery at the University of Genoa in the last 35 yr. Methods: We have retrospectively assessed all the radical nephrectomies performed between 1970 and 2005. Among tumours of the kidney subjected to surgical treatment during this period, we found 1105 cases of histologically proven renal cell carcinoma (RCC), 965 of which had records available for the study. The number of cases per year, symptoms at diagnosis, surgical strategy, staging of the tumour, and survival were rev…

Nephrologycancer incidencemedicine.medical_treatmentkidney carcinomamorbiditysepsisRenal cell carcinomacancer diagnosiscancer mortalitynephrectomypostoperative complicationMyocardial infarctioncancer survivaldisease free survivalcancer diagnosiadrenalectomy; article; cancer diagnosis; cancer incidence; cancer mortality; cancer size; cancer staging; cancer surgery; cancer survival; disease free survival; heart infarction; human; kidney carcinoma; lung embolism; lymphadenectomy; metastasis; morbidity; nephrectomy; partial nephrectomy; postoperative complication; priority journal; sepsis; spleen injury; splenectomy; surgical technique; thrombectomyRadical nephrectomyIncidence (epidemiology)articleadrenalectomyRenal cell carcinomaNephrectomypriority journalthrombectomysepsicancer surgerylung embolismmedicine.medical_specialtypartial nephrectomyUrologyheart infarctionsurgical techniquesplenectomyInternal medicinemedicineCarcinomametastasishumanbusiness.industrycancer stagingmedicine.diseaseSurgeryspleen injurycancer sizelymphadenectomySurgerymetastasibusinessKidney cancerKidney diseaseEuropean Urology Supplements
researchProduct

Sentinel node biopsy for malignant melanoma: a staging procedure only?

2010

Sentinel node biopsy (SNB) is an established staging tool for malignant melanoma. It allows identification of patients with metastatic disease at a very early stage and to collect accurate and complete prognostic information for these patients. Having noted that in a relevant percentage of patients the sentinel node is the only site of metastases, some authors have postulated a therapeutic role for SNB. In this paper, the possibility of a therapeutic role of SNB is evaluated. Relevant literature on the topic has been analyzed. Several findings suggest that not all patients with a positive SNB have further lymph node involvement. The prognostic indicators currently available do not significa…

OncologyBiologic markermedicine.medical_specialtymedicine.diagnostic_testbusiness.industryMelanomaSettore MED/19 - Chirurgia PlasticaDiseaseSentinel nodemedicine.diseasemedicine.anatomical_structureSentinel lymph node biopsy melanoma . Melanoma lymph node metastases . Melanoma prognosis . Prognostic false positivity . Melanoma lymphadenectomyInternal medicineStaging procedureBiopsymedicineSurgeryStage (cooking)businessLymph nodeEuropean Journal of Plastic Surgery
researchProduct

Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer

2023

Background: The aim of our study was to compare the number of lymph nodes removed during indocyanine green (ICG)-guided laparoscopic/robotic pelvic lymphadenectomy with standard systematic lymphadenectomy in endometrial cancer (EC) and cervical cancer (CC). Methods: This is a multicenter retrospective comparative study (Clinical Trial ID: NCT04246580; updated on 31 January 2023). Women affected by EC and CC who underwent laparoscopic/robotic systematic pelvic lymphadenectomy, with (cases) or without (controls) the use of ICG tracer injection within the uterine cervix, were included in the study. Results: The two groups were homogeneous for age (p = 0.08), Body Mass Index, International Fede…

indocyanine greenRobotic surgery.pelvic lymphadenectomycervical cancerHealth Toxicology and Mutagenesisendometrial cancerrobotic surgeryPublic Health Environmental and Occupational Healthlaparoscopygynecologic oncologySettore MED/40 - Ginecologia E Ostetriciaminimally invasive surgerycervical cancer; endometrial cancer; gynecologic oncology; indocyanine green; laparoscopy; minimally invasive surgery; pelvic lymphadenectomy; robotic surgery
researchProduct

Nationwide Analysis on Surgical Staging Procedures and Systemic Treatment for Patients With Endometrial Cancer in Germany

2012

ObjectiveIn 2009 and 2006, the Arbeitsgemeinschaft Gynäkologische Onkologie evaluated therapeutic approaches for endometrial carcinoma (EC) in Germany.Methods and MaterialsA questionnaire was developed and sent to 775 German gynecologic departments in 2009 (500 in 2006). The results of the questionnaires were compared with each other and with the recommendations of the Arbeitsgemeinschaft Gynäkologische Onkologie’s guideline. Subgroup analyses were performed, dividing the participating centers into small and large centers and into centers with less and more experience with EC.ResultsResponses were available in 33.3% in 2009 and 35.8% in 2006. Comparing 2009 with 2006, it became apparent tha…

medicine.medical_specialtyGynecologic oncologySurgical stagingGynecologic Surgical ProceduresGermanySurveys and QuestionnairesCytologyAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansMulticenter Studies as TopicPelvic lymphadenectomyDiagnostic Techniques Obstetrical and GynecologicalNeoplasm StagingGynecologybusiness.industryData CollectionGeneral surgeryEndometrial cancerObstetrics and GynecologyProfessional PracticeGuidelinemedicine.diseaseHospitalsPeritoneal washingEndometrial NeoplasmsOncologyLymph Node ExcisionFemaleGuideline AdherencebusinessCarcinoma EndometrioidInternational Journal of Gynecologic Cancer
researchProduct